CCR2 and myeloid sarcoma: In the Experimental Autoimmune Encephalomyelitis (EAE) mouse model, which mirrors brain inflammation and demyelination observed in MS, researchers have observed increased CCR2 expression during peak disease phases, correlating with the severity of MS.